Skip to main content
Quest Diagnostics

The Effect of Fasting on Serum Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA): A Report from a Large Reference Laboratory

AACC/ADLM 2024

The Association for Diagnostics & Laboratory Medicine (formerly ACC)

Chicago, IL, July 28-Aug 1, 2024

Poster presentation: The Effect of Fasting on Serum Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA): A Report from a Large Reference Laboratory

Authors: Richendollar B, Albeiroti S

Specialty: Endocrinology, Cardiology, Laboratory medicine

Related content

Audio Podcast
The power of laboratory analytics
Conference Presentation
HDL Apoliproteomic Score, Cardiometabolic Risk, and Exercise Training
Publication
Prognostic value of insulin resistance and hyperglycemia biomarkers for long-term risks of cardiometabolic outcomes
Publication
Lipid Distributions in the Global Diagnostics Network Across Five Continents
On-Demand Webinar
Cardiovascular Clinical Conversations: Inflammatory Markers for Defining Cardiovascular Risk

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.